Back to Search
Start Over
Fibroblast heterogeneity in prostate carcinogenesis.
- Source :
-
Cancer letters [Cancer Lett] 2022 Jan 28; Vol. 525, pp. 76-83. Date of Electronic Publication: 2021 Oct 29. - Publication Year :
- 2022
-
Abstract
- Our understanding of stromal components, specifically cancer-associated fibroblasts (CAF), in prostate cancer (PCa), has evolved from considering these cells as inert bystanders to acknowledging their significance as players in prostate tumorigenesis. CAF are multifaceted-they promote cancer cell growth, migration and remodel the tumor microenvironment. Although targeting CAF could be a promising strategy for PCa treatment, they incorporate a high but undefined degree of intrinsic cellular heterogeneity. The interaction between CAF subpopulations, with the normal and tumor epithelium and with other cell types is not yet characterized. Defining these interactions and the critical signaling nodes that support tumorigenesis will enable the development of novel strategies to control prostate cancer progression. Here we will discuss the origins, molecular and functional heterogeneity of CAF in PCa. We highlight the challenges associated with delineating CAF heterogeneity and discuss potential areas of research that would assist in expanding our knowledge of CAF and their role in PCa tumorigenesis.<br /> (Copyright © 2021 Elsevier B.V. All rights reserved.)
- Subjects :
- Cancer-Associated Fibroblasts metabolism
Cancer-Associated Fibroblasts pathology
Cell Lineage genetics
Epithelium metabolism
Epithelium pathology
Humans
Male
Prostatic Neoplasms pathology
Stromal Cells metabolism
Stromal Cells pathology
Carcinogenesis genetics
Genetic Heterogeneity
Prostatic Neoplasms genetics
Tumor Microenvironment genetics
Subjects
Details
- Language :
- English
- ISSN :
- 1872-7980
- Volume :
- 525
- Database :
- MEDLINE
- Journal :
- Cancer letters
- Publication Type :
- Academic Journal
- Accession number :
- 34715252
- Full Text :
- https://doi.org/10.1016/j.canlet.2021.10.028